New York State Common Retirement Fund Avidity Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 184,213 shares of RNA stock, worth $5.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
184,213
Previous 120,370
53.04%
Holding current value
$5.47 Million
Previous $4.92 Million
72.08%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding RNA
# of Institutions
252Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$316 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$274 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$256 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$241 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$209 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.55B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...